Proteon Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference December 11th
December 08, 2014 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Dec. 8, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics Announces Third Quarter 2014 Financial Results
November 25, 2014 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics Announces the Closing of Initial Public Offering and the Underwriters' Option to Purchase Additional Shares
November 24, 2014 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics to Present at the Stifel Nicolaus 2014 Healthcare Conference November 18th
November 17, 2014 08:49 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...